Seoulin Bioscience Co.Ltd (038070) — Free Cash Flow Generation Index
Seoulin Bioscience Co.Ltd (038070) has a Free Cash Flow Generation Index of 0.98x as of December 2025. Free cash flow of ₩620.87 Million represents 1% of operating cash flow (₩631.76 Million). See Seoulin Bioscience Co.Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Seoulin Bioscience Co.Ltd Free Cash Flow Generation Index (2013–2025)
Historical FCF Generation Index trend for Seoulin Bioscience Co.Ltd across 11 annual periods. Explore 038070 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Seoulin Bioscience Co.Ltd (2013–2025)
Year-by-year Free Cash Flow Generation Index for Seoulin Bioscience Co.Ltd. For the full company profile including market capitalisation, see 038070 company net worth.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.89x | ₩4.25 Billion | ₩4.76 Billion | ₩507.47 Million | ▲ +2004.7% |
| 2023 | -0.05x | ₩-43.65 Million | ₩930.57 Million | ₩974.21 Million | ▼ -105.8% |
| 2021 | 0.81x | ₩7.25 Billion | ₩8.92 Billion | ₩1.67 Billion | ▲ +9.2% |
| 2020 | 0.74x | ₩2.74 Billion | ₩3.68 Billion | ₩401.34 Million | ▼ -28.2% |
| 2019 | 1.04x | ₩7.59 Billion | ₩7.32 Billion | ₩269.29 Million | ▼ -5.6% |
| 2018 | 1.10x | ₩4.58 Billion | ₩4.17 Billion | ₩408.02 Million | ▼ -85.8% |
| 2017 | 7.71x | ₩10.03 Billion | ₩1.30 Billion | ₩8.73 Billion | ▲ +113.0% |
| 2016 | 3.62x | ₩9.97 Billion | ₩2.76 Billion | ₩7.21 Billion | ▲ +89.5% |
| 2015 | 1.91x | ₩7.86 Billion | ₩4.12 Billion | ₩3.74 Billion | ▲ +49.4% |
| 2014 | 1.28x | ₩3.50 Billion | ₩2.74 Billion | ₩761.57 Million | ▲ +26.4% |
| 2013 | 1.01x | ₩4.99 Billion | ₩4.94 Billion | ₩55.65 Million | — |